NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.
暂无分享,去创建一个
Philip Rosenstiel | Ateequr Rehman | Stefan Schreiber | S. Schreiber | P. Rosenstiel | B. Ryffel | M. Chamaillard | Grace Y Chen | G. Núñez | T. Grandjean | T. Sécher | O. Gaillot | A. Rehman | D. Hot | L. Huot | Y. Lemoine | A. De Arcangelis | A. Bressenot | Olivier Gaillot | Bernhard Ryffel | Mathias Chamaillard | S. Normand | A. Delanoye-Crespin | R. Haesler | A. Couturier-Maillard | Aurélie Couturier-Maillard | Thomas Secher | Sylvain Normand | Adèle De Arcangelis | Robert Haesler | Ludovic Huot | Teddy Grandjean | Aude Bressenot | Anne Delanoye-Crespin | Yves Lemoine | David Hot | Gabriel Nùñez | Grace Chen | Grace Y. Chen | S. Schreiber
[1] M. Karin,et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.
[2] P. Rosenstiel,et al. Nod2 is essential for temporal development of intestinal microbial communities , 2011, Gut.
[3] B. Pulendran,et al. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17–producing T cell responses , 2007, Nature Immunology.
[4] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[5] R. Kaul,et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens , 2011, Nature Medicine.
[6] B. Ryffel,et al. Remote control of intestinal tumorigenesis by innate immunity. , 2010, Cancer research.
[7] G. Church,et al. Systematic determination of genetic network architecture , 1999, Nature Genetics.
[8] Richard A. Flavell,et al. Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.
[9] J. Hampe,et al. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection , 2006, Cellular microbiology.
[10] S. Fisher,et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.
[11] Jeffrey N. Weiser,et al. Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.
[12] Michael Karin,et al. Inflammation and colon cancer. , 2010, Gastroenterology.
[13] Markus F Neurath,et al. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.
[14] M. Chamaillard,et al. Nods, Nalps and Naip: intracellular regulators of bacterial‐induced inflammation , 2003, Cellular microbiology.
[15] Richard A. Flavell,et al. NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.
[16] A. Macpherson,et al. Adaptation of Solitary Intestinal Lymphoid Tissue in Response to Microbiota and Chemokine Receptor CCR7 Signaling1 , 2006, The Journal of Immunology.
[17] F. Bäckhed,et al. Host-Bacterial Mutualism in the Human Intestine , 2005, Science.
[18] R. Knight,et al. Evolution of Mammals and Their Gut Microbes , 2008, Science.
[19] R Balfour Sartor,et al. Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.
[20] G. Núñez,et al. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. , 2008, Immunity.
[21] K. Doi,et al. Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. , 1996, Experimental animals.
[22] J. Scheller,et al. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. , 2011, The Journal of clinical investigation.
[23] J. Gordon,et al. Homeostasis and Inflammation in the Intestine , 2010, Cell.
[24] Judy H. Cho,et al. [Letters to Nature] , 1975, Nature.
[25] Tomohiro Watanabe,et al. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. , 2008, The Journal of clinical investigation.
[26] M. Chamaillard,et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury , 2011, Proceedings of the National Academy of Sciences.
[27] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[28] R. Gearry,et al. Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. , 2006, Cancer research.
[29] M. Neurath,et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo , 2000, Nature Medicine.
[30] M. Neurath,et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing , 2009, The Journal of experimental medicine.
[31] T. Yamamoto,et al. Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse , 2004, Alimentary pharmacology & therapeutics.
[32] T. Kishimoto,et al. IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis1 , 2000, The Journal of Immunology.
[33] S. Spechler,et al. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer , 2009, Nature Reviews Gastroenterology &Hepatology.
[34] Tomas Hrncir,et al. Nod2 is required for the regulation of commensal microbiota in the intestine , 2009, Proceedings of the National Academy of Sciences.
[35] M. Gazouli,et al. Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population , 2005, International journal of cancer.
[36] U Wahnschaffe,et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease , 2006, Gut.
[37] Wendy S. Garrett,et al. Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.
[38] M. Neurath,et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue , 2007, Nature Protocols.
[39] F. Shanahan,et al. Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.
[40] Rodney J Scott,et al. The NOD2 3020insC Mutation and the Risk of Colorectal Cancer , 2004, Cancer Research.
[41] Michael Krawczak,et al. Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer , 2009, BMC gastroenterology.
[42] P. Allen,et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. , 2011, Cell host & microbe.
[43] P. Vandamme,et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.
[44] P. Bork,et al. Enterotypes of the human gut microbiome , 2011, Nature.
[45] N. Pace,et al. Disease phenotype and genotype are associated with shifts in intestinal‐associated microbiota in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.
[46] T. Hirano,et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.
[47] P. Rosenstiel,et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation , 2012, Nature.
[48] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[49] S. Hunt,et al. Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post‐hepatectomy in mice , 2006, Hepatology.
[50] Marion Leclerc,et al. Altered gut microbiota composition in immune-impaired Nod2−/− mice , 2011, Gut.
[51] Andre Franke,et al. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.
[52] Ozge Canli,et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.
[53] Fiona Powrie,et al. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer , 2010, The Journal of experimental medicine.